| Genetic variation in CACNA1C affects brain circuitries related to mental illness KL Bigos, VS Mattay, JH Callicott, RE Straub, R Vakkalanka, B Kolachana, ... Archives of general psychiatry 67 (9), 939-945, 2010 | 361 | 2010 |
| Principles of gender-specific medicine MJ Legato, JP Bilezikian Gulf Professional Publishing, 2004 | 281 | 2004 |
| Sex, race, and smoking impact olanzapine exposure KL Bigos, BG Pollock, KC Coley, DD Miller, SR Marder, M Aravagiri, ... The Journal of Clinical Pharmacology 48 (2), 157-165, 2008 | 216 | 2008 |
| Acute 5-HT reuptake blockade potentiates human amygdala reactivity KL Bigos, BG Pollock, HJ Aizenstein, PM Fisher, RR Bies, AR Hariri Neuropsychopharmacology 33 (13), 3221-3225, 2008 | 180 | 2008 |
| Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review KL Bigos, BG Pollock, BA Stankevich, RR Bies Gender medicine 6 (4), 522-543, 2009 | 168 | 2009 |
| Suboptimal aminoglycoside dosing in critically ill patients RS Rea, B Capitano, R Bies, KL Bigos, R Smith, H Lee Therapeutic drug monitoring 30 (6), 674-681, 2008 | 161 | 2008 |
| Imaging genetics—days of future past KL Bigos, DR Weinberger Neuroimage 53 (3), 804-809, 2010 | 160 | 2010 |
| Genetic variation in CYP3A43 explains racial difference in olanzapine clearance KL Bigos, RR Bies, BG Pollock, JJ Lowy, F Zhang, DR Weinberger Molecular psychiatry 16 (6), 620-625, 2011 | 88 | 2011 |
| Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia JA Apud, F Zhang, H Decot, KL Bigos, DR Weinberger American Journal of Psychiatry 169 (7), 725-734, 2012 | 65 | 2012 |
| The influence of hormones and pharmaceutical agents on DHEA and DHEA‐S concentrations: a review of clinical studies FS Salek, KL Bigos, PD Kroboth The Journal of Clinical Pharmacology 42 (3), 247-266, 2002 | 58 | 2002 |
| Influence of DHEA administration on 24-hour cortisol concentrations PD Kroboth, JA Amico, RA Stone, M Folan, RF Frye, FJ Kroboth, KL Bigos, ... Journal of clinical psychopharmacology 23 (1), 96-99, 2003 | 52 | 2003 |
| Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants. RR Bies, KL Bigos, BG Pollock The journal of gender-specific medicine: JGSM: the official journal of the …, 2003 | 52 | 2003 |
| Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals D Dickinson, RE Straub, JW Trampush, Y Gao, N Feng, B Xie, JH Shin, ... JAMA psychiatry 71 (6), 647-656, 2014 | 50 | 2014 |
| Neuroimaging genetics: principles and practices KL Bigos, AR Hariri, DR Weinberger Oxford University Press, 2016 | 47 | 2016 |
| Dysregulation of neurosteroids in obsessive compulsive disorder KL Bigos, MM Folan, MR Jones, GL Haas, FJ Kroboth, PD Kroboth Journal of psychiatric research 43 (4), 442-445, 2009 | 36 | 2009 |
| Population pharmacokinetics in geriatric psychiatry KL Bigos, RR Bies, BG Pollock The American journal of geriatric psychiatry 14 (12), 993-1003, 2006 | 36 | 2006 |
| Association of missense mutation in FOLH1 with decreased NAAG levels and impaired working memory circuitry and cognition CF Zink, PB Barker, A Sawa, DR Weinberger, M Wang, H Quillian, ... American Journal of Psychiatry 177 (12), 1129-1139, 2020 | 35 | 2020 |
| Neuroimaging: technologies at the interface of genes, brain, and behavior KL Bigos, AR Hariri Neuroimaging Clinics of North America 17 (4), 459-467, 2007 | 30 | 2007 |
| Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status J Heide, F Zhang, KL Bigos, SA Mann, VJ Carr, C Shannon Weickert, ... American Journal of Psychiatry 173 (1), 53-59, 2016 | 26 | 2016 |
| Antipsychotic trials in schizophrenia: the CATIE project TS Stroup, JA Lieberman Cambridge University Press, 2010 | 17 | 2010 |
Daniel R. WeinbergerLieber Institute for Brain DevelopmentVerified email at libd.org
